What does PHARMACIE VR do?

PHARMACIE VR is a pharmacy in Quiévrain. Private Limited, started on 15 September 2017, 1 establishment.

What is the address of PHARMACIE VR?

The registered office of PHARMACIE VR is located at Rue Grande 37, 7380 Quiévrain.

Is PHARMACIE VR still active?

Yes. According to the CBE (17 September 2026) PHARMACIE VR is active, legal situation “Normale toestand”, started on 15 September 2017.

Is PHARMACIE VR registered on Peppol?

Yes, PHARMACIE VR is registered on the Peppol network with ID 0208:0681431631.

What is the enterprise number of PHARMACIE VR?

The enterprise number of PHARMACIE VR is BE0681431631.

When was PHARMACIE VR founded?

PHARMACIE VR was founded on 15 September 2017.

Who are the directors of PHARMACIE VR?

According to the 2025 annual accounts, the directors of PHARMACIE VR are: THERESE VAN RENTERGHEM.

Is PHARMACIE VR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 September 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE VR make in 2025?

PHARMACIE VR posted a profit after taxes of € 20,261 in financial year 2025.

What is the revenue of PHARMACIE VR?

As a small company, PHARMACIE VR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 103,045.

PHARMACIE VR (Private Limited) - Quiévrain - BE0681431631

Dossier PHARMACIE VR, printed on 17 September 2026 from databakkes.be/en/0681431631/pharmacie-vr. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE VR from Quiévrain, company number BE0681431631, closed financial year 2025 with a result of € 20,261 after tax. For that financial year PHARMACIE VR recorded a gross margin of € 103,045 and equity of € 65,106. Compared with financial year 2024, the result moved from € 12,797 to € 20,261. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Growing

€ 65,106

▲ 45% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 20,261

▲ 58% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 13,998

▲ € 13,667 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 52,706.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 48,414

▲ 1% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 54,388

▼ 36% vs 2024

€ 13,665 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 82,718

▲ 54% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 12,106

▲ 10% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 68,738 Gross margin 2022: € 68,738 First fiscal year in the series	€ 87,701 Gross margin 2023: € 87,701 ▲ 28% vs 2022 (€ 68,738) Favourable step	€ 97,210 Gross margin 2024: € 97,210 ▲ 11% vs 2023 (€ 87,701) Favourable step	€ 103,045 Gross margin 2025: € 103,045 ▲ 6% vs 2024 (€ 97,210) Favourable step	▲ 6%
Profit after taxes	€ -3,864 Profit after taxes 2022: € -3,864 First fiscal year in the series	€ 12,584 Profit after taxes 2023: € 12,584 ▲ € 16,448 vs 2022 (€ -3,864) Favourable step	€ 12,797 Profit after taxes 2024: € 12,797 ▲ 2% vs 2023 (€ 12,584) Favourable step	€ 20,261 Profit after taxes 2025: € 20,261 ▲ 58% vs 2024 (€ 12,797) Favourable step	▲ 58%
Equity	€ 19,464 Equity 2022: € 19,464 First fiscal year in the series	€ 32,048 Equity 2023: € 32,048 ▲ 65% vs 2022 (€ 19,464) Favourable step	€ 44,845 Equity 2024: € 44,845 ▲ 40% vs 2023 (€ 32,048) Favourable step	€ 65,106 Equity 2025: € 65,106 ▲ 45% vs 2024 (€ 44,845) Favourable step	▲ 45%
Total debts	€ 237,679 Total debts 2022: € 237,679 First fiscal year in the series	€ 208,238 Total debts 2023: € 208,238 ▼ 12% vs 2022 (€ 237,679) Favourable step	€ 158,068 Total debts 2024: € 158,068 ▼ 24% vs 2023 (€ 208,238) Favourable step	€ 158,525 Total debts 2025: € 158,525 Unchanged (€ 158,068) Unfavourable step
Cash	€ 8,892 Cash 2022: € 8,892 First fiscal year in the series	€ 2,753 Cash 2023: € 2,753 ▼ 69% vs 2022 (€ 8,892) Unfavourable step	€ 331 Cash 2024: € 331 ▼ 88% vs 2023 (€ 2,753) Unfavourable step	€ 13,998 Cash 2025: € 13,998 ▲ € 13,667 vs 2024 (€ 331) Favourable step	▲ € 13,667
Land & buildings	€ 3,019 Land & buildings 2022: € 3,019 First fiscal year in the series	€ 3,018 Land & buildings 2023: € 3,018 Unchanged (€ 3,019) Unchanged	€ 3,018 Land & buildings 2024: € 3,018 Unchanged (€ 3,018) Unchanged	€ 3,018 Land & buildings 2025: € 3,018 Unchanged (€ 3,018) Unchanged
Retained profit	€ 7,064 Retained profit 2022: € 7,064 First fiscal year in the series	€ 19,648 Retained profit 2023: € 19,648 ▲ 178% vs 2022 (€ 7,064) Favourable step	€ 32,445 Retained profit 2024: € 32,445 ▲ 65% vs 2023 (€ 19,648) Favourable step	€ 52,706 Retained profit 2025: € 52,706 ▲ 62% vs 2024 (€ 32,445) Favourable step	▲ 62%
Bank debt	€ 154,649 Bank debt 2022: € 154,649 First fiscal year in the series	€ 125,050 Bank debt 2023: € 125,050 ▼ 19% vs 2022 (€ 154,649) Favourable step	€ 85,183 Bank debt 2024: € 85,183 ▼ 32% vs 2023 (€ 125,050) Favourable step	€ 54,388 Bank debt 2025: € 54,388 ▼ 36% vs 2024 (€ 85,183) Favourable step	▼ 36%
Balance sheet total	€ 257,143 Balance sheet total 2022: € 257,143 First fiscal year in the series	€ 240,286 Balance sheet total 2023: € 240,286 ▼ 7% vs 2022 (€ 257,143) Unchanged	€ 202,913 Balance sheet total 2024: € 202,913 ▼ 16% vs 2023 (€ 240,286) Unchanged	€ 223,631 Balance sheet total 2025: € 223,631 ▲ 10% vs 2024 (€ 202,913) Unchanged	▲ 10%
Employees (FTE)	0.9 Employees (FTE) 2022: 0.9 First fiscal year in the series	-	-	-

Key figures of PHARMACIE VR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE VR?

What happened at PHARMACIE VR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: profit of € 20,261 (▲ 58% vs 2024). filed late Source: NBB ↗
Sep 19, 2017 New establishment in Quiévrain. KBO
Sep 15, 2017 Start of the company according to the CBE. KBO

In short

From € 3,864 loss in 2022 to € 20,261 profit in 2025.

Paid € 12,548 in corporate taxes since 2022.

Best year ever: 2025, with € 20,261 profit.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE VR? We notify you, reason included.

Follow PHARMACIE VR

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

THERESE VAN RENTERGHEM

PHARMACIE VR

Behind PHARMACIE VR is THERESE VAN RENTERGHEM.

See the full network in the app

Directors

According to the 2025 annual accounts

THERESE VAN RENTERGHEM

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Grande 37

7380 Quiévrain

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0681.431.631
VAT number: BE 0681.431.631
Registered office: Rue Grande 37, 7380 Quiévrain
Names & denominations: PHARMACIE VR
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 September 2017
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗